{"schema_version":"secwatch.filing_event.v1","accession":"0001193125-25-039199","form_type":"8-K","ticker":"WW","cik":"0000105319","company_name":"WW INTERNATIONAL, INC.","filed_at":"2025-02-27T23:59:59+00:00","discovered_at":"2026-05-14T18:03:02.816672+00:00","generated_at":"2026-05-26T00:58:03.064843+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"WW International Q4 net income $25.1M vs loss; names Tara Comonte permanent CEO","bullets":["Q4 revenue $184.4M (-10.5% YoY); subscription rev down 7.3%; clinical subscription rev $20.5M (+57.9%).","Q4 net income $25.1M vs loss $88.1M; adj. EPS $0.32 vs -$0.84; adj. EBITDAS margin 27.4% (+1109 bps).","Full-year revenue $785.9M; net loss $345.7M incl. $293.2M impairment; adj. operating income $104.8M.","3.3M end-of-period subscribers, including 92k clinical; targeting $100M run-rate cost savings by end of 2025.","Board appointed Tara Comonte as permanent President & CEO effective Feb 26, 2025 (was interim)."],"urls":{"canonical":"https://secwatch.observer/filing/0001193125-25-039199","json":"https://secwatch.observer/filing/0001193125-25-039199.json","markdown":"https://secwatch.observer/filing/0001193125-25-039199.md","text":"https://secwatch.observer/filing/0001193125-25-039199.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/105319/000119312525039199/0001193125-25-039199-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/105319/000119312525039199/d135020d8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-26T00:58:03.064843+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}